arrow
T

Talal Hilal

Mayo Clinic
H指数:18
被引数:1,224

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Autologous haematopoietic stem cell transplant consolidation and survival outcomes in primary central nervous system lymphoma: Evidence from the National Cancer Database

自体造血干细胞移植巩固治疗对原发性中枢神经系统淋巴瘤患者生存结局的影响:国家癌症数据库的证据

2026-09-300
PRE
Coronary Artery Calcification as a Predictor of Survival in Patients Receiving Post-transplant Cyclophosphamide for GVHD Prophylaxis

冠状动脉钙化作为接受移植后环磷酰胺预防GVHD患者的生存预测因子

2026-09-012
OAAI
Impact of Conditioning Regimen Intensity and Total Body Irradiation on Outcomes of Allogeneic Hematopoietic Cell Transplantation for Mature T-Cell Lymphomas: A Multicenter Analysis

异基因造血细胞移植中预处理方案强度和全身照射对成熟T细胞淋巴瘤预后的影响:一项多中心分析

2026-08-100
PRE
Improved Outcomes with TKI Maintenance Following Brexucabtagene Autoleucel in Philadelphia-chromosome ALL

在费城染色体阳性急性淋巴细胞白血病中使用Brexucabtagene Autoleucel治疗后,TKI维持疗法可改善疗效

2026-06-290
OA
Comparison of Fludarabine Versus Bendamustine as a Lymphodepleting Chemotherapy Prior to CAR-T for Large Cell Lymphoma

与贝antasine相比,氟达拉滨作为大细胞淋巴瘤CAR-T治疗前淋巴清除化疗的比较

2026-06-240
PREAI
Consensus Recommendations for CAR T Cell Administration in Adult Acute Lymphoblastic Leukemia: A Modified Delphi Study

成人急性淋巴细胞白血病CAR T细胞输注的共识建议:一项改良德尔菲研究

Blood
IF23.1
2026-05-220
PRE
Mutational Profiling Links Biologically Relevant Variants to Multi-Systemic Rosai-Dorfman Disease

突变谱分析将生物学相关的变异与多系统性罗西-道夫曼病联系起来

2026-05-220
OAAI
Central nervous system involvement in patients with Richter transformation of chronic lymphocytic leukemia (CLL): the Mayo Clinic experience

慢性淋巴细胞白血病(CLL)患者中Richter转化的中枢神经系统受累:梅奥诊所的经验

2026-01-070
OAAI
CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia

CAR HEMATOTOX 独立预测急性淋巴细胞白血病接受CD19 CAR-T疗法后的结局

2025-10-080
OAAI
Cardiovascular Degeneration in Erdheim-Chester Disease: Prevalence, Burden, and Outcomes

Erdheim-Chester 病中的心血管退行性变:患病率、负担和结局

2025-09-030
OAAI
The impact of social determinants of health on outcomes of brexucabtagene autoleucel in adults with relapsed/refractory B-cell acute lymphoblastic leukemia

社会决定因素对成人复发/难治性B细胞急性淋巴细胞白血病患者brexucabtagene autoleucel治疗结局的影响

2025-08-230
OAAI
Chimeric antigen receptor T-cell therapy for high-grade B-cell lymphoma NOS

嵌合抗原受体T细胞疗法治疗高级别B细胞淋巴瘤NOS

2025-07-220
PRE
The role of imaging studies in predicting time to first treatment and overall survival in high-count monoclonal B-cell lymphocytosis

高计数单克隆B细胞淋巴细胞增多症中影像学研究在预测首次治疗时间及总生存期方面的作用

2025-07-150
PRE
Comparison of Frontline Therapies in Older Adults Age ≥ 80 Years With Chronic Lymphocytic Leukemia (CLL): A Mayo Clinic and Danish Nation-Wide Study

比较年龄≥80岁慢性淋巴细胞白血病(CLL)老年患者一线疗法:一项梅奥诊所与丹麦全国性研究

2025-06-180
PRE